478 related articles for article (PubMed ID: 26865587)
1. Obesity and Breast Cancer: Molecular Interconnections and Potential Clinical Applications.
Simone V; D'Avenia M; Argentiero A; Felici C; Rizzo FM; De Pergola G; Silvestris F
Oncologist; 2016 Apr; 21(4):404-17. PubMed ID: 26865587
[TBL] [Abstract][Full Text] [Related]
2. Obesity-associated Breast Cancer: Analysis of risk factors.
Engin A
Adv Exp Med Biol; 2017; 960():571-606. PubMed ID: 28585217
[TBL] [Abstract][Full Text] [Related]
3. Role of adipokines and cytokines in obesity-associated breast cancer: therapeutic targets.
Khan S; Shukla S; Sinha S; Meeran SM
Cytokine Growth Factor Rev; 2013 Dec; 24(6):503-13. PubMed ID: 24210902
[TBL] [Abstract][Full Text] [Related]
4. Effects of obesity on transcriptomic changes and cancer hallmarks in estrogen receptor-positive breast cancer.
Fuentes-Mattei E; Velazquez-Torres G; Phan L; Zhang F; Chou PC; Shin JH; Choi HH; Chen JS; Zhao R; Chen J; Gully C; Carlock C; Qi Y; Zhang Y; Wu Y; Esteva FJ; Luo Y; McKeehan WL; Ensor J; Hortobagyi GN; Pusztai L; Fraser Symmans W; Lee MH; Yeung SC
J Natl Cancer Inst; 2014 Jul; 106(7):. PubMed ID: 24957076
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers of inflammation and breast cancer risk: a case-control study nested in the EPIC-Varese cohort.
Agnoli C; Grioni S; Pala V; Allione A; Matullo G; Gaetano CD; Tagliabue G; Sieri S; Krogh V
Sci Rep; 2017 Oct; 7(1):12708. PubMed ID: 28983080
[TBL] [Abstract][Full Text] [Related]
6. Hyperresistinemia is associated with postmenopausal breast cancer.
Dalamaga M; Karmaniolas K; Papadavid E; Pelekanos N; Sotiropoulos G; Lekka A
Menopause; 2013 Aug; 20(8):845-51. PubMed ID: 23481121
[TBL] [Abstract][Full Text] [Related]
7. Nicotinamide phosphoribosyl-transferase/visfatin: a missing link between overweight/obesity and postmenopausal breast cancer? Potential preventive and therapeutic perspectives and challenges.
Dalamaga M
Med Hypotheses; 2012 Nov; 79(5):617-21. PubMed ID: 22922056
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
[TBL] [Abstract][Full Text] [Related]
9. A novel role for insulin resistance in the connection between obesity and postmenopausal breast cancer.
Weichhaus M; Broom J; Wahle K; Bermano G
Int J Oncol; 2012 Aug; 41(2):745-52. PubMed ID: 22614942
[TBL] [Abstract][Full Text] [Related]
10. Effect of genetic variants and traits related to glucose metabolism and their interaction with obesity on breast and colorectal cancer risk among postmenopausal women.
Jung SY; Sobel EM; Papp JC; Zhang ZF
BMC Cancer; 2017 Apr; 17(1):290. PubMed ID: 28446149
[TBL] [Abstract][Full Text] [Related]
11. Interaction of insulin-like growth factor-I and insulin resistance-related genetic variants with lifestyle factors on postmenopausal breast cancer risk.
Jung SY; Ho G; Rohan T; Strickler H; Bea J; Papp J; Sobel E; Zhang ZF; Crandall C
Breast Cancer Res Treat; 2017 Jul; 164(2):475-495. PubMed ID: 28478612
[TBL] [Abstract][Full Text] [Related]
12. Correlates of obesity in postmenopausal women with breast cancer: comparison of genetic, demographic, disease-related, life history and dietary factors.
Wasserman L; Flatt SW; Natarajan L; Laughlin G; Matusalem M; Faerber S; Rock CL; Barrett-Connor E; Pierce JP
Int J Obes Relat Metab Disord; 2004 Jan; 28(1):49-56. PubMed ID: 14557830
[TBL] [Abstract][Full Text] [Related]
13. Obesity, inflammation, and postmenopausal breast cancer: therapeutic implications.
Macciò A; Madeddu C
ScientificWorldJournal; 2011; 11():2020-36. PubMed ID: 22125453
[TBL] [Abstract][Full Text] [Related]
14. Insulin and leptin levels in obese patients with and without breast cancer.
Romero-Figueroa Mdel S; Garduño-García Jde J; Duarte-Mote J; Matute-González G; Gómez-Villanueva A; De la Cruz-Vargas J
Clin Breast Cancer; 2013 Dec; 13(6):482-5. PubMed ID: 24084031
[TBL] [Abstract][Full Text] [Related]
15. Deregulated microRNAs and Adiponectin in Postmenopausal Women with Breast Cancer.
Peña-Cano MI; Saucedo R; Morales-Avila E; Valencia J; Zavala-Moha JA; López A
Gynecol Obstet Invest; 2019; 84(4):369-377. PubMed ID: 30650411
[TBL] [Abstract][Full Text] [Related]
16. Role of inflammation in obesity-related breast cancer.
Crespi E; Bottai G; Santarpia L
Curr Opin Pharmacol; 2016 Dec; 31():114-122. PubMed ID: 27889687
[TBL] [Abstract][Full Text] [Related]
17. The Molecular and Genetic Interactions between Obesity and Breast Cancer Risk.
Ajabnoor GMA
Medicina (Kaunas); 2023 Jul; 59(7):. PubMed ID: 37512149
[TBL] [Abstract][Full Text] [Related]
18. Aromatase overexpression in dysfunctional adipose tissue links obesity to postmenopausal breast cancer.
Wang X; Simpson ER; Brown KA
J Steroid Biochem Mol Biol; 2015 Sep; 153():35-44. PubMed ID: 26209254
[TBL] [Abstract][Full Text] [Related]
19. Physical activity and postmenopausal breast cancer: proposed biologic mechanisms and areas for future research.
Neilson HK; Friedenreich CM; Brockton NT; Millikan RC
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):11-27. PubMed ID: 19124476
[TBL] [Abstract][Full Text] [Related]
20. Upper abdominal obesity, insulin resistance and breast cancer risk.
Stoll BA
Int J Obes Relat Metab Disord; 2002 Jun; 26(6):747-53. PubMed ID: 12037643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
